An open-label, randomized efficacy and safety trial of subcutaneous and intramuscular BT088 (Fovepta) human hepatitis B immunoglobulin in neonates of HBV-carrier mothers
Details
The content you want to view is only available to Zendy Plus users.Already have an account? Click here. to sign in.